Market Place
Sourcing Support
EicOsis Initiates Phase 1b Clinical Trial of EC5026
30 Jan 2024 //
PR NEWSWIRE
EicOsis Successfully Completes Phase 1a Clinical Trial of EC5026
17 Nov 2020 //
PRNEWSWIRE
EicOsis EC5026 Granted Fast Track Designation by FDA for Neuropathic Pain
09 Apr 2020 //
ADVFN
EicOsis Announces FDA Acceptance of IND Application for EC5026
10 Oct 2019 //
PRNEWS WIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.